#{text}
NHS Employers chief executive calls for a "long term solution to sustainable inv...
Read more
Trials will evaluate the effect of Jardiance on exercise ability and heart failu...
Four world-leading researchers win €1m prize for contribution to neuroscience....
Verpora Group will help improve patient access to life-enhancing medicines....
Colorectal cancer is second most common cause of cancer-related mortality in Eur...
Ruling relates to information issued to media in September 2017 around Novo Nord...
Early indication of how likely treatment is to work might allow physicians to ad...
SNF472 is lead candidate for treatment of orphan disease calciphylaxis....
Recipharm will co-develop value added meds using Altus' drug delivery technologi...
Dapagliflozin is selective SLGT-2 inhibitor for adults with type-1 diabetes....
Study met its primary endpoint....
Click here for the latest issue and to subscribe.